Eli Lilly / iHEA / GE Healthcare / Expert Group / /
Continent
Africa / Asia / North America / /
Country
France / Japan / Brazil / Canada / United Kingdom / China / Finland / India / Denmark / Germany / Micronesia / Mexico / Sweden / Turkey / United States / Lebanon / /
Currency
SEK / USD / EUR / /
Event
Diplomatic Relations / /
Facility
National Institute / Skånes University Hospital / Karolinska Institute / /
IndustryTerm
treatment of HER2 positive breast cancer / cancer therapy / pharmaceuticals / treatment of breast cancer / healthcare cost / healthcare costs / i.e. healthcare costs / breast cancer care / care systems / direct healthcare costs / /
MedicalCondition
Well organized breast cancer / crude cancer / times Breast cancer / Quality Adjusted Life breast cancer / estimated disease / illness / breast cancer / breast and gi cancer / Cancer / limited cancer / diseases / Breat cancer / oral cancer / Swedish cost‐of‐illness / important and interesting breast cancer / female breast cancer / total breast cancer / metastatic breast cancer / obesity / Figure 2a Breast cancer / cancers / HER2 positive breast cancer / breast cancers / common cancer / disease / tumour / sickness / different cost cancer / breast cancer A / female cancer / /
MedicalTreatment
radiotherapy / Surgery / cancer therapy / breast surgery / contraception / chemoprevention / hormone therapy / biological therapies / hormonal therapy / /
Organization
World Health Organization / Council on Technology Assessment / United Nations Industrial Development Organization / OECD / Breast and GI Cancer Unit / Skånes University Hospital / National Social Insurance Board / National Board of Health and He / European Union / Karolinska Institute Academy of Cancer Sciences / NHS / Professor Bengt Jönsson Economists Association / Swedish Health Economics Association / Karolinska University Hospital Board / Stockholm School of Economics / Karolinska Institute / Center for Health Economics / Scientific Advisory Board / Organization of Health Services / Committee on Funding / Department of Oncology / National Institute for Clinical Excellence / department of oncology at Skånes University Hospital / /
Person
Nils Wilking / Bengt Jönsson / /
Position
Advisor / president / head / Director of the Associate / Professor Emeritus / Professor / Executive / temporary adviser / Associate Professor / CONTENTS Executive / consultant / Chair of the Expert Group / senior research physician / past president / member / Chair / /
Product
Herceptin / /
PublishedMedium
Health Economics / /
Region
Northern Africa / Western Asia / Northern Europe / Middle East / Nordic countries / Central America / Eastern Asia / Central Asia / Western Europe / Southern Europe / Western Africa / Eastern Africa / Central Europe / Southern Africa / Eastern Europe / /
Prevention and the economic burden of breast cancer A report commissioned by GE Healthcare, authored by Bengt Jönsson and Nils Wilking